Connecting Data to People

Integrated Testing Strategy for Skin Sensitisation

 

Allergic contact dermatitis (aka., skin sensitisation) accounts for 20% of all contact dermatitis cases and has an estimated annual cost of $200 million. It is also a public health problem, responsible for more than seven million outpatient visits annually. Currently, there are more than 3700 substances that are identified as contact allergens.

Douglas Connect provides an open implementation of the integrated testing strategy (ITS) that assesses skin sensitisation potency based on an approach developed at Proctor and Gamble.

The DC-ITS implementation combines information from three validated alternative assays (DPRA, KeratinoSens and h-CLAT) with in silico predictions for bioavailability using open cheminformatics tools from the community.

DC-ITS allows scientists to evaluate the skin sensitisation hazard of their chemicals using a combination of in vitro and in silico tools. It automatically compensates for the missing experimental data by using predicted values and utilizes the expert-knowledge embedded in the skin sensitization adverse outcome pathway (AOP). More

 

 

Dr Noffisat Oki
Bioinformatics Scientist

 

 

 

 

Rok Predan
Sales Manager

 

 

EwC CONNECTIONS

Latest Tweets

Edelweiss Connect (3 weeks ago)
RT @iseult5: @nanocommons month18 meeting well underway! Updates from Cristiana on project status and @EdelweissConn Thomas Exner on our #n…
Edelweiss Connect (3 weeks ago)
RT @openrisknet: We are pleased to announce the final @OpenRiskNet workshop that will be organised in #Amsterdam, The Netherlands on 23-24…
Edelweiss Connect (3 weeks ago)
RT @MauriceAtEcvam: We're hiring! If you are specialist in organ-on-chip technologies and systems then please apply to come join our team @…
Edelweiss Connect (3 weeks ago)
RT @nanotechia: Come say hi to @EdelweissConn at #Nanopavilion2019 Stand B316 at #ChemspecEurope ! #nano #nanomaterials #nanotechnology ht…
Edelweiss Connect (4 weeks ago)
Learn more about our recently launched application at #Chemspec Europe 2019. SaferSkin uses an ITS approach to prov… https://t.co/AVDsDMgrVE

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com